NCT06016270 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06016270
Title	A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	STCube, Inc.
Indications	lung small cell carcinoma
Therapies	hSTC810 + Paclitaxel
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 8 of 8 entries

Facility	Status	City	State	Zip	Country	Details
Asan Medical Center	RECRUITING	Seoul		05505	Korea, Republic of	Details
Korea University Anam Hospital	RECRUITING	Seoul		02841	Korea, Republic of	Details
MD Anderson Cancer Center	NOT_YET_RECRUITING	Houston	Texas	77030	United States	Details
Samsung Medical Center	RECRUITING	Seoul		06351	Korea, Republic of	Details
Seoul National University Bundang Hospital	RECRUITING	Seoul		13620	Korea, Republic of	Details
Seoul National University Hospital	RECRUITING	Seoul		03080	Korea, Republic of	Details
The Catholic University of Korea St. Vincent's Hospital	RECRUITING	Suwon		16247	Korea, Republic of	Details
Tisch Cancer Institute at Mount Sinai	NOT_YET_RECRUITING	New York	New York	10029	United States	Details

Showing 1 to 8 of 8 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06016270Clinical Trial Detail